Increased platelet:RBC ratios are associated with improved survival after massive transfusion.

BACKGROUND Several recent military and civilian trauma studies demonstrate that improved outcomes are associated with early and increased use of plasma-based resuscitation strategies. However, outcomes associated with platelet transfusions are poorly characterized. We hypothesized that increased platelet:red blood cells (RBC) ratios would decrease hemorrhagic death and improve survival after massive transfusion (MT). METHODS A transfusion database of patients transported from the scene to 22 Level I Trauma Centers over 12 months in 2005 to 2006 was reviewed. MT was defined as receiving ≥ 10 RBC units within 24 hours of admission. To mitigate survival bias, 25 patients who died within 60 minutes of arrival were excluded from analysis. Six random donor platelet units were considered equal to a single apheresis platelet unit. Admission and outcome data associated with the low (>1:20), medium (1:2), and high (1:1) platelet:RBC ratios were examined. These groups were based on the median value of the tertiles for the ratio of platelets:RBC units. RESULTS Two thousand three hundred twelve patients received at least one unit of blood and 643 received an MT. Admission vital signs, INR, temperature, pH, Glasgow Coma Scale, Injury Severity Score, and age were similar between platelet ratio groups. The average admission platelet counts were lower in the patients who received the high platelet:RBC ratio versus the low ratio (192 vs. 216, p = 0.03). Patients who received MT were severely injured, with a mean (± standard deviation) Injury Severity Score of 33 ± 16 and received 22 ± 15 RBCs and 11 ± 14 platelets within 24 hours of injury. Increased platelet ratios were associated with improved survival at 24 hours and 30 days (p < 0.001 for both). Truncal hemorrhage as a cause of death was decreased (low: 67%, medium: 60%, high: 47%, p = 0.04). Multiple organ failure mortality was increased (low: 7%, medium: 16%, high: 27%, p = 0.003), but overall 30-day survival was improved (low: 52%, medium: 57%, high: 70%) in the high ratio group (medium vs. high: p = 0.008; low vs. high: p = 0.007). CONCLUSION Similar to recently published military data, transfusion of platelet:RBC ratios of 1:1 was associated with improved early and late survival, decreased hemorrhagic death and a concomitant increase in multiple organ failure-related mortality. Based on this large retrospective study, increased and early use of platelets may be justified, pending the results of prospective randomized transfusion data.

[1]  P. Rhee,et al.  The impact of platelet transfusion in massively transfused trauma patients. , 2010, Journal of the American College of Surgeons.

[2]  Jodie L. Conyers,et al.  Protective effects of fresh frozen plasma on vascular endothelial permeability, coagulation, and resuscitation after hemorrhagic shock are time dependent and diminish between days 0 and 5 after thaw. , 2010, The Journal of trauma.

[3]  A. Perner,et al.  Hypocoagulability, as evaluated by thrombelastography, at admission to the ICU is associated with increased 30-day mortality , 2010, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[4]  Jeffrey McCullough,et al.  Dose of prophylactic platelet transfusions and prevention of hemorrhage. , 2010, The New England journal of medicine.

[5]  M. Cohen,et al.  Early release of high mobility group box nuclear protein 1 after severe trauma in humans: role of injury severity and tissue hypoperfusion , 2009, Critical care.

[6]  John B Holcomb,et al.  Resuscitation and transfusion principles for traumatic hemorrhagic shock. , 2009, Blood reviews.

[7]  A. Peitzman,et al.  Fresh frozen plasma is independently associated with a higher risk of multiple organ failure and acute respiratory distress syndrome. , 2009, The Journal of trauma.

[8]  David A Spain,et al.  Massive transfusion protocols: the role of aggressive resuscitation versus product ratio in mortality reduction. , 2009, Journal of the American College of Surgeons.

[9]  E. Moore,et al.  The emerging role of rapid thromboelastography in trauma care. , 2009, The Journal of trauma.

[10]  G. Rozycki,et al.  Improvements in early mortality and coagulopathy are sustained better in patients with blunt trauma after institution of a massive transfusion protocol in a civilian level I trauma center. , 2009, The Journal of trauma.

[11]  J. Holcomb,et al.  A high ratio of plasma and platelets to packed red blood cells in the first 6 hours of massive transfusion improves outcomes in a large multicenter study. , 2009, American journal of surgery.

[12]  Paige E. Waterman,et al.  An evaluation of the impact of apheresis platelets used in the setting of massively transfused trauma patients. , 2009, The Journal of trauma.

[13]  A. Exadaktylos,et al.  Can RapidTEG accelerate the search for coagulopathies in the patient with multiple injuries? , 2009, The Journal of trauma.

[14]  P. Rhee,et al.  Impact of plasma transfusion in massively transfused trauma patients. , 2009, The Journal of trauma.

[15]  Richard L. George,et al.  The relationship of blood product ratio to mortality: survival benefit or survival bias? , 2009, The Journal of trauma.

[16]  T. Scalea,et al.  The prevalence of abnormal results of conventional coagulation tests on admission to a trauma center , 2009, Transfusion.

[17]  P. Johansson,et al.  Effect of Haemostatic Control Resuscitation on mortality in massively bleeding patients: a before and after study , 2008, Vox sanguinis.

[18]  A. Peitzman,et al.  An FFP:PRBC transfusion ratio >/=1:1.5 is associated with a lower risk of mortality after massive transfusion. , 2008, The Journal of trauma.

[19]  Kevin Mackway-Jones,et al.  The coagulopathy of trauma: a review of mechanisms. , 2008, The Journal of trauma.

[20]  M. Parr,et al.  Management of coagulopathy in the patients with multiple injuries: results from an international survey of clinical practice. , 2008, The Journal of trauma.

[21]  M. Parr,et al.  Traumatic coagulopathy: where are the good experimental models? , 2008, The Journal of trauma.

[22]  S. Rafii,et al.  Platelets, petechiae, and preservation of the vascular wall. , 2008, The New England journal of medicine.

[23]  M. Dubick,et al.  Thrombelastography is better than PT, aPTT, and activated clotting time in detecting clinically relevant clotting abnormalities after hypothermia, hemorrhagic shock and resuscitation in pigs. , 2008, The Journal of trauma.

[24]  B. Cotton,et al.  Optimizing outcomes in damage control resuscitation: identifying blood product ratios associated with improved survival. , 2008, The Journal of trauma.

[25]  J. Michalek,et al.  Increased Plasma and Platelet to Red Blood Cell Ratios Improves Outcome in 466 Massively Transfused Civilian Trauma Patients , 2008, Annals of surgery.

[26]  R. Lefering,et al.  Red blood cell to plasma ratios transfused during massive transfusion are associated with mortality in severe multiply injury: a retrospective analysis from the Trauma Registry of the Deutsche Gesellschaft für Unfallchirurgie , 2008, Vox sanguinis.

[27]  T. Scalea,et al.  Giving plasma at a 1:1 ratio with red cells in resuscitation: who might benefit? , 2008, Transfusion.

[28]  J. Duchesne,et al.  Review of current blood transfusions strategies in a mature level I trauma center: were we wrong for the last 60 years? , 2008, The Journal of trauma.

[29]  C. Wade,et al.  Increased mortality associated with the early coagulopathy of trauma in combat casualties. , 2008, The Journal of trauma.

[30]  B. Cotton,et al.  Damage control hematology: the impact of a trauma exsanguination protocol on survival and blood product utilization. , 2008, The Journal of trauma.

[31]  P. Rhee,et al.  Massive transfusion in trauma patients: tissue hemoglobin oxygen saturation predicts poor outcome. , 2008, The Journal of trauma.

[32]  C. Wade,et al.  Combining early coagulation and inflammatory status improves prediction of mortality in burned and nonburned trauma patients. , 2008, The Journal of trauma.

[33]  C. Wade,et al.  Effect of plasma and red blood cell transfusions on survival in patients with combat related traumatic injuries. , 2008, The Journal of trauma.

[34]  C. Wade,et al.  A reduction in clot formation rate and strength assessed by thrombelastography is indicative of transfusion requirements in patients with penetrating injuries. , 2008, The Journal of trauma.

[35]  C. Wade,et al.  The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. , 2007, The Journal of trauma.

[36]  A. Bennaghmouch,et al.  Microparticles adhere to collagen type I, fibrinogen, von Willebrand factor and surface immobilised platelets at physiological shear rates , 2007, British journal of haematology.

[37]  P. Johansson,et al.  The blood bank: from provider to partner in treatment of massively bleeding patients , 2007, Transfusion.

[38]  E. Mazyala,et al.  Soft and hard-tissue augmentation with platelet-rich plasma. tissue culture dynamics, regeneration and molecular biology perspective. , 2007 .

[39]  N. Secher,et al.  Proactive administration of platelets and plasma for patients with a ruptured abdominal aortic aneurysm: evaluating a change in transfusion practice , 2007, Transfusion.

[40]  Dougald M Monroe,et al.  Coagulation 2006: a modern view of hemostasis. , 2007, Hematology/oncology clinics of North America.

[41]  Michael A Dubick,et al.  Damage control resuscitation: directly addressing the early coagulopathy of trauma. , 2007, The Journal of trauma.

[42]  P. Austin,et al.  Quantifying the impact of survivor treatment bias in observational studies. , 2006, Journal of evaluation in clinical practice.

[43]  R. Maier,et al.  Patterns of Errors Contributing to Trauma Mortality: Lessons Learned From 2594 Deaths , 2006, Annals of surgery.

[44]  J. Minei,et al.  Inflammation and the host response to injury, a large-scale collaborative project: Patient-oriented research core-standard operating procedures for clinical care. IV. Guidelines for transfusion in the trauma patient. , 2006, The Journal of trauma.

[45]  Andrew D. Rosenberg,et al.  Practice guidelines for perioperative blood transfusion and adjuvant therapies: An updated report by the American Society of Anesthesiologists Task Force on perioperative blood transfusion and adjuvant therapies , 2006 .

[46]  J. Hess.  An update on solutions for red cell storage , 2006, Vox sanguinis.

[47]  J. Hess,et al.  Massive transfusion practices around the globe and a suggestion for a common massive transfusion protocol. , 2006, The Journal of trauma.

[48]  J. Hess,et al.  Indications for early fresh frozen plasma, cryoprecipitate, and platelet transfusion in trauma. , 2006, The Journal of trauma.

[49]  Alan D. Lopez,et al.  Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data , 2006, The Lancet.

[50]  David B Hoyt,et al.  Damage control resuscitation: the need for specific blood products to treat the coagulopathy of trauma , 2006, Transfusion.

[51]  W. Jochum,et al.  Platelet-Derived Serotonin Mediates Liver Regeneration , 2006, Science.

[52]  A. Ho,et al.  Are we giving enough coagulation factors during major trauma resuscitation? , 2005, American journal of surgery.

[53]  M. B. Hansen,et al.  Transfusion practice in massively bleeding patients: time for a change? , 2005, Vox sanguinis.

[54]  C. Ball,et al.  Effects of low temperature on shear-induced platelet aggregation and activation. , 2004, The Journal of trauma.

[55]  J. Duguid,et al.  Guidelines for the use of fresh‐frozen plasma, cryoprecipitate and cryosupernatant , 2004, British journal of haematology.

[56]  J. Como,et al.  Blood transfusion rates in the care of acute trauma , 2004, Transfusion.

[57]  A. Wolberg,et al.  A systematic evaluation of the effect of temperature on coagulation enzyme activity and platelet function. , 2004, The Journal of trauma.

[58]  R. Marx.  Platelet-rich plasma: evidence to support its use. , 2004, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[59]  Mauricio Lynn,et al.  Early coagulopathy predicts mortality in trauma. , 2003, The Journal of trauma.

[60]  Karim Brohi,et al.  Acute traumatic coagulopathy. , 2003, The Journal of trauma.

[61]  S. Kleinman,et al.  Risks associated with transfusion of cellular blood components in Canada. , 2003, Transfusion medicine reviews.

[62]  A. Hirshberg,et al.  Minimizing dilutional coagulopathy in exsanguinating hemorrhage: a computer simulation. , 2003, The Journal of trauma.

[63]  Lloyd G. Greenwald,et al.  Time to laparotomy for intra-abdominal bleeding from trauma does affect survival for delays up to 90 minutes. , 2002, The Journal of trauma.

[64]  I. Wakabayashi,et al.  Extracellular pH affects platelet aggregation associated with modulation of store-operated Ca(2+) entry. , 2001, Thrombosis research.

[65]  S. Wilson,et al.  Improved survival following massive transfusion in patients who have undergone trauma. , 1999, Archives of surgery.

[66]  A. von Ruecker,et al.  Difficulties in determining prophylactic transfusion thresholds of platelets in leukemia patients. , 1998, Blood.

[67]  P Hollingsworth-Fridlund,et al.  Lethal injuries and time to death in a level I trauma center. , 1998, Journal of the American College of Surgeons.

[68]  A. Sauaia,et al.  Predicting life-threatening coagulopathy in the massively transfused trauma patient: hypothermia and acidoses revisited. , 1997, The Journal of trauma.

[69]  Andrew D. Rosenberg,et al.  Practice Guidelines for Blood Component Therapy: A Report by the American Society of Anesthesiologists Task Force on Blood Component Therapy , 1996, Anesthesiology.

[70]  A. E. Horvath,et al.  Practice parameter for the use of fresh-frozen plasma, cryoprecipitate, and platelets. Fresh-Frozen Plasma, Cryoprecipitate, and Platelets Administration Practice Guidelines Development Task Force of the College of American Pathologists. , 1994, JAMA.

[71]  A. Sauaia,et al.  Epidemiology of Trauma Deaths , 1993 .

[72]  L. Horstman,et al.  Clinical significance of platelet microparticles in autoimmune thrombocytopenias. , 1992, The Journal of laboratory and clinical medicine.

[73]  S. Khuri,et al.  Hypothermia-induced reversible platelet dysfunction. , 1987, Annals of surgery.

[74]  S. Hanson,et al.  Platelet kinetics in patients with bone marrow hypoplasia: evidence for a fixed platelet requirement , 1985 .

[75]  E. Mammen,et al.  Serial changes in primary hemostasis after massive transfusion. , 1985, Surgery.

[76]  T. Simon,et al.  Hemostasis in Massively Transfused Trauma Patients , 1979, Annals of surgery.

[77]  J. Collins,et al.  Coagulation Disorders in Combat Casulties: I. Acute Changes after Wouding II. Effects of Massive Transfusion III. Post‐Resuscitative Changes , 1969, Annals of surgery.

[78]  M. Parr,et al.  Educational initiative on critical bleeding in trauma: Chicago, July 11-13, 2008. , 2010, The Journal of trauma.

[79]  B. Cotton,et al.  Predefined massive transfusion protocols are associated with a reduction in organ failure and postinjury complications. , 2009, The Journal of trauma.

[80]  C. Cocanour,et al.  Fresh frozen plasma should be given earlier to patients requiring massive transfusion. , 2007, The Journal of trauma.

[81]  F. Brenneman,et al.  Preventable deaths from hemorrhage at a level I Canadian trauma center. , 2007, The Journal of trauma.

[82]  J. Hess.  Blood and coagulation support in trauma care. , 2007, Hematology. American Society of Hematology. Education Program.

[83]  Peter Rhee,et al.  Preventable or potentially preventable mortality at a mature trauma center. , 2007, The Journal of trauma.

[84]  P. Rhee,et al.  Trauma fatalities: time and location of hospital deaths. , 2004, Journal of the American College of Surgeons.

[85]  D. Heimbach,et al.  Prophylactic platelet administration during massive transfusion. A prospective, randomized, double-blind clinical study. , 1986, Annals of surgery.

[86]  S. Ostrowski,et al.  Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine Thrombelastography and Tromboelastometry in Assessing Coagulopathy in Trauma , 2022 .